Gainers
- Lipella Pharmaceuticals LIPO shares rose 123.2% to $5.76 during Thursday's pre-market session. The company's market cap stands at $6.9 million.
- Invivyd IVVD shares increased by 25.11% to $2.64. The company's market cap stands at $315.7 million.
- Rani Therapeutics Hldgs RANI stock rose 17.36% to $1.69. The market value of their outstanding shares is at $56.2 million.
- Silexion Therapeutics SLXN stock moved upwards by 13.86% to $1.56. The market value of their outstanding shares is at $6.2 million.
- MBX Biosciences MBX shares increased by 11.11% to $12.5. The market value of their outstanding shares is at $417.7 million.
- Xencor XNCR shares increased by 9.01% to $19.1. The company's market cap stands at $1.3 billion.
Losers
- Avinger AVGR stock fell 37.5% to $0.35 during Thursday's pre-market session. The company's market cap stands at $1.1 million.
- Pasithea Therapeutics KTTA shares decreased by 33.95% to $1.81. The market value of their outstanding shares is at $2.2 million.
- Protagenic Therapeutics PTIX stock decreased by 21.52% to $0.29. The company's market cap stands at $2.1 million.
- Sensus Healthcare SRTS stock decreased by 16.58% to $7.5. The company's market cap stands at $122.9 million. The company's, Q4 earnings came out yesterday.
- Mustang Bio MBIO stock decreased by 14.96% to $2.56. The company's market cap stands at $3.3 million.
- Moleculin Biotech MBRX stock fell 14.3% to $0.85. The company's market cap stands at $2.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
IVVDInvivyd Inc
$2.4616.6%
KTTAPasithea Therapeutics Corp
$1.88-31.4%
LIPOLipella Pharmaceuticals Inc
$5.0194.2%
MBIOMustang Bio Inc
$2.60-13.6%
MBRXMoleculin Biotech Inc
$0.8336-15.9%
MBXMBX Biosciences Inc
$12.127.73%
PTIXProtagenic Therapeutics Inc
$0.2800-25.3%
RANIRani Therapeutics Holdings Inc
$1.6917.0%
SLXNSilexion Therapeutics Corp
$1.5815.3%
SRTSSensus Healthcare Inc
$7.50-16.6%
XNCRXencor Inc
$19.109.02%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in